company background image
300406 logo

Beijing Strong BiotechnologiesInc SZSE:300406 Stock Report

Last Price

CN¥14.47

Market Cap

CN¥8.5b

7D

-5.4%

1Y

-31.0%

Updated

14 Jul, 2024

Data

Company Financials +

Beijing Strong Biotechnologies,Inc.

SZSE:300406 Stock Report

Market Cap: CN¥8.5b

300406 Stock Overview

Beijing Strong Biotechnologies, Inc. offers in-vitro diagnostics products and services in the People’s Republic of China and internationally.

300406 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends3/6

Beijing Strong Biotechnologies,Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Strong BiotechnologiesInc
Historical stock prices
Current Share PriceCN¥14.47
52 Week HighCN¥21.78
52 Week LowCN¥14.30
Beta0.31
11 Month Change-12.04%
3 Month Change-17.92%
1 Year Change-31.00%
33 Year Change-28.44%
5 Year Change1.05%
Change since IPO180.70%

Recent News & Updates

Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price

Jul 03
Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price

An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued

Jun 14
An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued

Recent updates

Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price

Jul 03
Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price

An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued

Jun 14
An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued

Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?

Mar 21
Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?

Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified

Mar 03
Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified

Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)

Feb 27
Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)

Shareholder Returns

300406CN BiotechsCN Market
7D-5.4%1.0%1.2%
1Y-31.0%-22.7%-18.5%

Return vs Industry: 300406 underperformed the CN Biotechs industry which returned -22.7% over the past year.

Return vs Market: 300406 underperformed the CN Market which returned -18.5% over the past year.

Price Volatility

Is 300406's price volatile compared to industry and market?
300406 volatility
300406 Average Weekly Movement4.9%
Biotechs Industry Average Movement6.4%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 300406's share price has been volatile over the past 3 months.

Volatility Over Time: 300406's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20011,094Xi Liuwww.bsbe.com.cn

Beijing Strong Biotechnologies, Inc. offers in-vitro diagnostics products and services in the People’s Republic of China and internationally. The company provides clinical biochemistry products, such as reagents and automatic biochemistry analyzers; coagulation products, including reagents and automated coagulation analyzers; pathology and liquid buiopsy and serology products comprising blood type test cards and automated blood grouping analyzers. In addition, it engages in the rental of healthcare instruments; and offers inspection services.

Beijing Strong Biotechnologies,Inc. Fundamentals Summary

How do Beijing Strong BiotechnologiesInc's earnings and revenue compare to its market cap?
300406 fundamental statistics
Market capCN¥8.48b
Earnings (TTM)CN¥533.37m
Revenue (TTM)CN¥1.76b

15.9x

P/E Ratio

4.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300406 income statement (TTM)
RevenueCN¥1.76b
Cost of RevenueCN¥441.34m
Gross ProfitCN¥1.32b
Other ExpensesCN¥787.41m
EarningsCN¥533.37m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 23, 2024

Earnings per share (EPS)0.91
Gross Margin74.95%
Net Profit Margin30.27%
Debt/Equity Ratio30.3%

How did 300406 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

22%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.